Pharsight

Drugs that contain Ozenoxacin

1. Xepi patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6335447 FERRER INTERNACIONAL Quinolonecarboxylic acid derivatives or salts thereof
Nov, 2023

(3 months ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9399014 FERRER INTERNACIONAL Pharmaceutical topical compositions
Dec, 2029

(5 years from now)

US9180200 FERRER INTERNACIONAL Pharmaceutical topical compositions
Jan, 2032

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Dec 11, 2022

NCE-1 date: 2021-12-11

Market Authorisation Date: 11 December, 2017

Treatment: Treatment of impetigo due to staphylococcus aureus or streptococcus pyogenes

Dosage: CREAM;TOPICAL

More Information on Dosage

XEPI family patents

Family Patents